Literature DB >> 8739258

The role of structure-based ligand design and molecular modelling in drug discovery.

J P Tollenaere1.   

Abstract

Structure-based ligand design is a technique that is used in the initial stages of a drug development programme. The role of various computational methods in the characterization of the chemical properties and behaviour of molecular systems is discussed. The determination of the three-dimensional properties of small molecules and macromolecular receptor structures is a core activity in the efforts towards a better understanding of structure-activity relationships.

Mesh:

Substances:

Year:  1996        PMID: 8739258     DOI: 10.1007/bf00579706

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  14 in total

1.  The computer program LUDI: a new method for the de novo design of enzyme inhibitors.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1992-02       Impact factor: 3.686

2.  The Protein Data Bank: a computer-based archival file for macromolecular structures.

Authors:  F C Bernstein; T F Koetzle; G J Williams; E F Meyer; M D Brice; J R Rodgers; O Kennard; T Shimanouchi; M Tasumi
Journal:  J Mol Biol       Date:  1977-05-25       Impact factor: 5.469

Review 3.  Strategies for indirect computer-aided drug design.

Authors:  G H Loew; H O Villar; I Alkorta
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

4.  Discovery of nanomolar ligands for 7-transmembrane G-protein-coupled receptors from a diverse N-(substituted)glycine peptoid library.

Authors:  R N Zuckermann; E J Martin; D C Spellmeyer; G B Stauber; K R Shoemaker; J M Kerr; G M Figliozzi; D A Goff; M A Siani; R J Simon
Journal:  J Med Chem       Date:  1994-08-19       Impact factor: 7.446

5.  The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1994-06       Impact factor: 3.686

6.  Automated molecular design: a new fragment-joining algorithm.

Authors:  A R Leach; S R Kilvington
Journal:  J Comput Aided Mol Des       Date:  1994-06       Impact factor: 3.686

7.  Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors.

Authors:  P Y Lam; P K Jadhav; C J Eyermann; C N Hodge; Y Ru; L T Bacheler; J L Meek; M J Otto; M M Rayner; Y N Wong
Journal:  Science       Date:  1994-01-21       Impact factor: 47.728

8.  A quantitative structure-activity relationship and molecular graphics analysis of hydrophobic effects in the interactions of inhibitors with alcohol dehydrogenase.

Authors:  C Hansch; T Klein; J McClarin; R Langridge; N W Cornell
Journal:  J Med Chem       Date:  1986-05       Impact factor: 7.446

9.  Does the solid-state structure of endothelin-1 provide insights concerning the solution-state conformational equilibrium?

Authors:  G M Lee; C Chen; T M Marschner; N H Andersen
Journal:  FEBS Lett       Date:  1994-11-28       Impact factor: 4.124

10.  The relation between the divergence of sequence and structure in proteins.

Authors:  C Chothia; A M Lesk
Journal:  EMBO J       Date:  1986-04       Impact factor: 11.598

View more
  2 in total

1.  Testing and validation of the Automated Topology Builder (ATB) version 2.0: prediction of hydration free enthalpies.

Authors:  Katarzyna B Koziara; Martin Stroet; Alpeshkumar K Malde; Alan E Mark
Journal:  J Comput Aided Mol Des       Date:  2014-01-30       Impact factor: 3.686

2.  2L-PCA: a two-level principal component analyzer for quantitative drug design and its applications.

Authors:  Qi-Shi Du; Shu-Qing Wang; Neng-Zhong Xie; Qing-Yan Wang; Ri-Bo Huang; Kuo-Chen Chou
Journal:  Oncotarget       Date:  2017-08-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.